OR WAIT null SECS
© 2024 MJH Life Sciences and BioPharm International. All rights reserved.
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Peter Cramer is a subject matter expert in Process Architecture at Jacobs.
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.